Catalyst Wire Dossier Catalyst Wire Dossier

brolucizumab 6 mg

brolucizumab · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for brolucizumab 6 mg, covering 2020-04-30 to 2020-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD [Phase 3]

See pricing